Ablation of OGT, and thus O-GlcNAcylation, in skeletal muscle (mKO) resulted in increased energy expenditure, improved insulin sensitivity, protection against HFD-induced obesity, and dysregulation of muscle interleukin-15 (Il15) expression. The gene discussed is OGT; the disease is obesity disorder.